These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 24884749)

  • 1. The economics of resistant pathogens and antibiotic innovation.
    McKellar MR; Chernew ME; Fendrick AM
    Am J Manag Care; 2014 Mar; 20(3):193-7. PubMed ID: 24884749
    [No Abstract]   [Full Text] [Related]  

  • 2. Improving antibiotic markets for long-term sustainability.
    Kesselheim AS; Outterson K
    Yale J Health Policy Law Ethics; 2011; 11(1):101-67. PubMed ID: 21381513
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibiotic resistance--problems, progress, and prospects.
    Nathan C; Cars O
    N Engl J Med; 2014 Nov; 371(19):1761-3. PubMed ID: 25271470
    [No Abstract]   [Full Text] [Related]  

  • 4. A three-step plan for antibiotics.
    Nature; 2014 May; 509(7502):533. PubMed ID: 24877183
    [No Abstract]   [Full Text] [Related]  

  • 5. Stimulating antibiotic development.
    Tillotson G
    Lancet Infect Dis; 2010 Jan; 10(1):2-3. PubMed ID: 20129141
    [No Abstract]   [Full Text] [Related]  

  • 6. Countries mull over incentives for developing antibiotics.
    Anderson T
    Lancet; 2016 May; 387(10031):1894-5. PubMed ID: 27203638
    [No Abstract]   [Full Text] [Related]  

  • 7. Target small firms for antibiotic innovation.
    Hwang TJ; Carpenter D; Kesselheim AS
    Science; 2014 May; 344(6187):967-9. PubMed ID: 24876477
    [No Abstract]   [Full Text] [Related]  

  • 8. Lack of funding could undermine UK antibiotic resistance strategy, say experts.
    O'Dowd A
    BMJ; 2013 Dec; 347():f7618. PubMed ID: 24355390
    [No Abstract]   [Full Text] [Related]  

  • 9. The 10 x '20 Initiative: pursuing a global commitment to develop 10 new antibacterial drugs by 2020.
    Infectious Diseases Society of America
    Clin Infect Dis; 2010 Apr; 50(8):1081-3. PubMed ID: 20214473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pay drug companies $1bn for each new antibiotic, says report.
    Owen J
    BMJ; 2016 May; 353():i2863. PubMed ID: 27198868
    [No Abstract]   [Full Text] [Related]  

  • 11. Novel Programs and Discoveries Aim to Combat Antibiotic Resistance.
    Hampton T
    JAMA; 2015 Jun 23-30; 313(24):2411-3. PubMed ID: 26039283
    [No Abstract]   [Full Text] [Related]  

  • 12. Preclinical antibiotic pipeline gets a pick-me-up.
    Mullard A
    Nat Rev Drug Discov; 2017 Oct; 16(11):741-742. PubMed ID: 29081528
    [No Abstract]   [Full Text] [Related]  

  • 13. New blood: Creative funding of disease-specific research.
    Seaman WE; Locksley RM; Welsh MJ
    Sci Transl Med; 2015 May; 7(288):288ed5. PubMed ID: 25995219
    [No Abstract]   [Full Text] [Related]  

  • 14. Overcoming the current deadlock in antibiotic research.
    Schäberle TF; Hack IM
    Trends Microbiol; 2014 Apr; 22(4):165-7. PubMed ID: 24698433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Public funding of clinical-stage antibiotic development in the United States and European Union.
    Eichberg MJ
    Health Secur; 2015; 13(3):156-65. PubMed ID: 26042859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Perspective on Incentives for Novel Inpatient Antibiotics: No One-Size-Fits-All.
    Bhatti T; Lum K; Holland S; Sassman S; Findlay D; Outterson K
    J Law Med Ethics; 2018 Jun; 46(1_suppl):59-65. PubMed ID: 30146959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the GAIN Act a turning point in new antibiotic discovery?
    Brown ED
    Can J Microbiol; 2013 Mar; 59(3):153-6. PubMed ID: 23540332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Innovation of novel antibiotics: an economic perspective.
    McKellar MR; Fendrick AM
    Clin Infect Dis; 2014 Oct; 59 Suppl 3():S104-7. PubMed ID: 25261536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urgent steps to tackle antibiotic resistance are needed despite government review, say MPs.
    O'Dowd A
    BMJ; 2014 Jul; 348():g4472. PubMed ID: 25002152
    [No Abstract]   [Full Text] [Related]  

  • 20. Novel approaches are needed to develop tomorrow's antibacterial therapies.
    Spellberg B; Bartlett J; Wunderink R; Gilbert DN
    Am J Respir Crit Care Med; 2015 Jan; 191(2):135-40. PubMed ID: 25590154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.